American Century Companies
BCAB icon

American Century Companies’s BioAtla BCAB Stock Holding History

American Century Companies’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-868
Closed -$59.4K – 2896
2024
Q2 		$59.4K Buy
868
+230
+36% +$27.4K ﹤0.01% 2853
2024
Q1 		$110K Buy
+638
New +$79.3K ﹤0.01% 2852
2023
Q4 		– Sell
-498
Closed -$42.3K – 2881
2023
Q3 		$42.3K Buy
498
+128
+35% +$16.3K ﹤0.01% 2817
2023
Q2 		$55.5K Buy
+370
New +$63.6K ﹤0.01% 2759

Other funds holding BCAB

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

American Century Companies's BCAB Position: Q3 2024 in Review

American Century Companies sold out of BioAtla (BCAB) in Q3 2024, closing a stake of 868 shares — an estimated $59.4K sold.

American Century Companies first reported a position in BCAB in Q2 2023 and held it in 4 quarters. The position peaked at $110K in Q1 2024. 63 funds tracked by Wall St. Rank hold BCAB as of Q3 2024.

  • American Century Companies reported no remaining BioAtla position as of Q3 2024 after selling out during the quarter.
  • American Century Companies sold 868 BioAtla shares in Q3 2024, an estimated $59.4K.
  • American Century Companies first reported a position in BioAtla in Q2 2023 and held it in 4 quarters.
  • American Century Companies's BioAtla position peaked at $110K in Q1 2024.
  • 63 funds tracked by Wall St. Rank held BioAtla as of Q3 2024.

Based on American Century Companies's 13F filing for Q3 2024, filed 12 Nov 2024.